Carlos Jimenez – Managing Director, B. Braun Aesculap Mexico
Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum…
Regenerative medicine aims to replace or regenerate damaged cells, tissues, or organs, both structurally and functionally, which have lost their optimal biological regulatory condition. Regeneration in nature can occur at the cellular, tissue, organ, structural, and even whole body levels, but in humans is naturally significantly limited with aging.
To achieve a transformational level of technological advancement in this area for humans, RegenerAge is utilizing novel combination applications of biological interventions, including stem cells, soluble regenerative biologics, proprietary nutritional bio-products, functional and regenerative based diets, bioidentical hormone replacement, and skin / aesthetic rejuvenation tools, yielding an unprecedented, integrated option for activating the natural healing processes of the body and maintaining health and wellness.
Regenerative medicine incorporates various fields of science, including genetics, biomedical engineering, tissue engineering, advanced cell technology, and evolutionary dynamics, with the goal of allowing human bodies to recover cellular function, vitality and optimizing its integrated operation.
Smart prevention is the best initial approach for any disease, but once an illness manifests as part of a person’s life, regeneration and repair are invaluable options to restore health and restructure damaged tissues and cells within the human body. Recent biotechnology related advances present wonderful opportunities for RegenerAge to improve outcomes when patients need more than traditional treatments, as well as to increase lifespan and wellness for those conscious about their health and longevity.
RegenerAge is open to working with all types of patients according to their medical status. Our treatments may help patients who suffer from a variety of chronic degenerative diseases including, but not limited to: cardiovascular conditions, diabetes, kidney damage, different types of cancer, auto-immune diseases, CNS degeneration, and hematological disorders.
Contact
Address: BNY Mellon Center 1735 Market Street, Suite 3750 Philadelphia PA 19103 USA
Tel. +52 55 3028 4783
Website: https://regenerage.clinic/es/
Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum…
Brothers Juan José and Andrés Aguirre Salazar of Grupo Bruluart talk about the company’s most important milestones and how they are institutionalizing the family business to prepare the firm for…
Clinical research and access are the name of the game. The Executive Director of the association bringing together the most important research-based pharmaceutical companies discusses how the association has stepped…
The genomic revolution represents a before and after in the field of medicine. Sistemas Genómicos has understood this back in 1998 and today is the largest private organization offering DNA…
The general manager for Cegedim Mexico, Central America and the Caribbean discusses how the company is diversifying its product portfolio to tap into new business segments and attend new clients…
Boehringer Ingelheim is turning 130 in 2015. Miguel Salazar, president and country managing director for Mexico, explains how he is steering the company to bypass the currents of the ever-changing…
‘Health is the milestone of any society’. The former minister of health and former dean of Mexico’s most important university discusses the vision behind the creation of thought-leading institutions such…
Besides protecting the health of Mexicans, COFEPRIS today offers an important value-added to the investment community: predictability. The organization’s commissioner shares the astonishing results of his last three years of…
Biograft is the first private tissue bank in Mexico meeting the increasing demand for implants of human musculoskeletal tissue. The general director and founder discusses the vision behind the creation…
Merck is getting “Fit for 2018”. Pedro Galvis, the company’s managing director for Mexico, discusses how the company’s transformation program, implemented in 2012, is ensuring future growth and how Mexico’s…
Novo Nordisk’s market access and public affairs director discusses the state of diabetes management in Mexico, highlighting the government’s recent commitment to tackle this public health issue and the company’s…
Alejandro Luna and José Alfredo Sedano, lawyers at the leading legal firm of Santamarina y Steta, discuss the current legal challenges faced by companies in the pharmaceutical and healthcare sector…
See our Cookie Privacy Policy Here
